the EuroSIDA study 2021, ' Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort ', Journal of Acquired Immune Deficiency Syndromes, vol. 87, no. 2, pp. 806-817 . https://doi.org/10.1097/QAI.0000000000002635 Pelchen-Matthews, A, Borges, Á H, Reekie, J, Rasmussen, L D, Wiese, L, Weber, J, Pradier, C, Degen, O, Paredes, R, Tau, L, Flamholc, L, Gottfredsson, M, Kowalska, J, Jablonowska, E, Mozer-Lisewska, I, Radoi, R, Vasylyev, M, Kuznetsova, A, Begovac, J, Svedhem, V, Clark, A, Cozzi-Lepri, A & EuroSIDA Study 2021, ' Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort ', Journal of acquired immune deficiency syndromes (1999), vol. 87, no. 2, pp. 806-817 . https://doi.org/10.1097/QAI.0000000000002635 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname
Annals of internal medicine, 174(6), 768-776. American College of Physicians For the D:A:D Study Group 2021, ' Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy : A multinational prospective cohort study ', Annals of Internal Medicine, vol. 174, no. 6, pp. 768-776 . https://doi.org/10.7326/M20-5226 Chammartin, F, Lodi, S, Logan, R, Ryom, L, Mocroft, A, Kirk, O, D'Arminio Monforte, A, Reiss, P, Phillips, A, El-Sadr, W, Hatleberg, C I, Pradier, C, Bonnet, F, Law, M, De Wit, S, Sabin, C, Lundgren, J D, Bucher, H C, Friis-Møller, N, Pedersen, C & For the D:A:D Study Group 2021, ' Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy : A multinational prospective cohort study ', Annals of Internal Medicine, vol. 174, no. 6, pp. 768-776 . https://doi.org/10.7326/M20-5226 Annals of Internal Medicine Annals of Internal Medicine, American College of Physicians, 2021, ⟨10.7326/M20-5226⟩ Annals of Internal Medicine, 174(6), 768-776. American College of Physicians Annals of Internal Medicine, 174(6), 768-776. AMER COLL PHYSICIANS
The Respond Study Group 2022, ' Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium ', HIV Medicine, vol. 23, no. 8, pp. 895-910 . https://doi.org/10.1111/hiv.13273 Byonanebye, Dathan M; Polizzotto, Mark N; Neesgaard, Bastian; Sarcletti, Mario; Matulionyte, Raimonda; Braun, Dominique L; Castagna, Antonella; de Wit, Stéphane; Wit, Ferdinand; Fontas, Eric; Vehreschild, Jörg Janne; Vesterbacka, Jan; Greenberg, Lauren; Hatleberg, Camilla; Garges, Harmony; Gallant, Joel; Volny Anne, Alain; Öllinger, Angela; Mozer-Lisewska, Iwona; Surial, Bernard; ... (2022). Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. HIV medicine, 23(8), pp. 895-910. Wiley 10.1111/hiv.13273 HIV medicine, Hoboken : Wiley, 2022, vol. 23, iss. 8, p. 895-910 HIV medicine, 23(8), 895-910. Wiley-Blackwell